{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:00:37Z","timestamp":1777518037591,"version":"3.51.4"},"reference-count":19,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.4161\/hv.23190","type":"journal-article","created":{"date-parts":[[2013,2,20]],"date-time":"2013-02-20T21:20:30Z","timestamp":1361395230000},"page":"874-878","source":"Crossref","is-referenced-by-count":17,"title":["Human papillomavirus vaccine uptake among 9\u201317 year old males in the United States: The National Health Interview Survey, 2010"],"prefix":"10.1080","volume":"9","author":[{"given":"Tabassum H.","family":"Laz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahbubur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbey B.","family":"Berenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,10,27]]},"reference":[{"key":"R1","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jadohealth.2011.03.010","article-title":"Age-specific prevalence of human papillomavirus infection in males: a global review","volume":"48","author":"Smith","year":"2011","journal-title":"J Adolesc Health"},{"key":"R2","doi-asserted-by":"crossref","first-page":"K17","DOI":"10.1016\/j.vaccine.2008.06.021","article-title":"Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions","volume":"26","author":"Giuliano","year":"2008","journal-title":"Vaccine"},{"key":"R3","doi-asserted-by":"crossref","unstructured":"Lacey CJ, Lowndes CM, Shah KV. Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6\/11 disease. Vaccine 2006;24(suppl. 3):S3\/35-S3\/41.","DOI":"10.1016\/j.vaccine.2006.06.015"},{"key":"R4","first-page":"630","article-title":"FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R5","first-page":"1705","article-title":"Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R6","unstructured":"Advisory Committee on Immunization Practices. Vaccines for Children program-vaccines to prevent human papillomavirus; 2009. Available at: http:\/\/www.cdc.gov\/vaccines\/programs\/vfc\/downloads\/resolutions\/10-11-1-hpv.pdf. Retrieved June 17, 2012."},{"key":"R7","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1016\/j.vaccine.2011.06.020","article-title":"HPV vaccine and adolescent males","volume":"29","author":"Reiter","year":"2011","journal-title":"Vaccine"},{"key":"R8","first-page":"1117","article-title":"National and state vaccination coverage among adolescents aged 13 through 17 years--United States, 2010","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jadohealth.2009.04.021","article-title":"Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey","volume":"45","author":"Caskey","year":"2009","journal-title":"J Adolesc Health"},{"key":"R10","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jadohealth.2009.03.029","article-title":"Human papillomavirus vaccine initiation in an area with elevated rates of cervical cancer","volume":"45","author":"Gottlieb","year":"2009","journal-title":"J Adolesc Health"},{"key":"R11","first-page":"1100","article-title":"Vaccination coverage among adolescents aged 13-17 years - United States, 2007","volume":"57","author":"Centers for Disease Control and Prevention (CDC)","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R12","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Markowitz","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"R13","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jadohealth.2005.07.014","article-title":"Pediatricians\u2019 intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes","volume":"37","author":"Kahn","year":"2005","journal-title":"J Adolesc Health"},{"key":"R14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jpag.2005.09.004","article-title":"Attitudes about human papillomavirus vaccine among family physicians","volume":"18","author":"Riedesel","year":"2005","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jadohealth.2010.03.003","article-title":"Human papillomavirus vaccination of males: attitudes and perceptions of physicians who vaccinate females","volume":"47","author":"Weiss","year":"2010","journal-title":"J Adolesc Health"},{"key":"R16","unstructured":"Food and Drug Administration. Highlights of prescribing information. Gardasil (human papillomavirus quadrivalent [types 6, 11, 16 and 18]). Silver Spring, MD: Food and Drug Administration; 2011. Available at http:\/\/www.fda.gov\/downloads\/biologicsbloodvaccines\/vaccines\/approvedproducts\/ucm111263.pdf. Retrieved June 17, 2012."},{"key":"R17","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1158\/1055-9965.EPI-09-1287","article-title":"Does framing human papillomavirus vaccine as preventing cancer in men increase vaccine acceptability?","volume":"19","author":"McRee","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R18","first-page":"997","article-title":"National, state, and local area vaccination coverage among adolescents aged 13-17 years--United States, 2008","volume":"58","author":"Centers for Disease Control and Prevention (CDC)","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R19","unstructured":"National Center for Health Statistics. National Health Interview Survey (NHIS), 2010. Public use data release: NHIS Survey Description. Available at: ftp:\/\/ftp.cdc.gov\/pub\/Health_Statistics\/NCHS\/Dataset_Documentation\/NHIS\/2010\/srvydesc.pdf. Retrieved June 5, 2012."}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.4161\/hv.23190","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T23:30:39Z","timestamp":1562715039000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/abs\/10.4161\/hv.23190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":19,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,10,27]]},"published-print":{"date-parts":[[2013,4]]}},"alternative-id":["10.4161\/hv.23190"],"URL":"https:\/\/doi.org\/10.4161\/hv.23190","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}